Mariacarla Andreozzi
University of Basel(CH)
Publications by Year
Research Areas
Genetic factors in colorectal cancer, Hepatocellular Carcinoma Treatment and Prognosis, Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers, Breast Cancer Treatment Studies
Most-Cited Works
- → PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patients(2014)603 cited
- → Human and Mouse VEGFA -Amplified Hepatocellular Carcinomas Are Highly Sensitive to Sorafenib Treatment(2014)184 cited
- → Genomic amplification of 9p24.1 targeting JAK2, PD-L1, and PD-L2 is enriched in high-risk triple negative breast cancer(2015)135 cited
- → JAK2 and PD-L1 Amplification Enhance the Dynamic Expression of PD-L1 in Triple-negative Breast Cancer(2018)67 cited
- → HMGA1 Expression in Human Hepatocellular Carcinoma Correlates with Poor Prognosis and Promotes Tumor Growth and Migration in in vitro Models(2016)64 cited
- → High NRBP1 expression in prostate cancer is linked with poor clinical outcomes and increased cancer cell growth(2012)31 cited
- → Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i+): The OPBC-05/ICARO Study(2024)29 cited
- → VEGFA gene locus analysis across 80 human tumour types reveals gene amplification in several neoplastic entities(2013)26 cited
- → Association of Axillary Dissection With Systemic Therapy in Patients With Clinically Node-Positive Breast Cancer(2023)24 cited
- → Development and validation of a novel clinical fluorescence in situ hybridization assay to detect JAK2 and PD-L1 amplification: a fluorescence in situ hybridization assay for JAK2 and PD-L1 amplification(2017)24 cited